Fujimaki Y - Search Results

1

Urinary metabolites of DX-8951, a novel camptothecin analog, in rats and humans.

Atsumi R, Oguma T, Yoshioka N, Konno T, Okazaki O, Fujimaki Y. Atsumi R, et al. Among authors: fujimaki y. Arzneimittelforschung. 2001;51(3):253-7. doi: 10.1055/s-0031-1300032. Arzneimittelforschung. 2001. PMID: 11304942 Clinical Trial.

2

Pharmacokinetics and disposition of DY-9760e, a novel calmodulin antagonist, in rats and monkeys.

Tachibana S, Fujimaki Y, Tachibana M, Tanaka M, Kurata T, Okazaki O, Sudo K. Tachibana S, et al. Among authors: fujimaki y. Arzneimittelforschung. 2005;55(3):135-44. doi: 10.1055/s-0031-1296835. Arzneimittelforschung. 2005. PMID: 15819385

3

Metabolism of ticlopidine in rats: identification of the main biliary metabolite as a glutathione conjugate of ticlopidine S-oxide.

Shimizu S, Atsumi R, Nakazawa T, Fujimaki Y, Sudo K, Okazaki O. Shimizu S, et al. Among authors: fujimaki y. Drug Metab Dispos. 2009 Sep;37(9):1904-15. doi: 10.1124/dmd.109.027524. Epub 2009 Jun 18. Drug Metab Dispos. 2009. PMID: 19541827

4

Metabolism of the calmodulin antagonist DY-9760e in animals and humans.

Tachibana S, Tanaka M, Fujimaki Y, Suzuki W, Ookuma T, Ohori Y, Hayashi KI, Iwata H, Okazaki O, Sudo KI. Tachibana S, et al. Among authors: fujimaki y. Xenobiotica. 2005 May;35(5):499-517. doi: 10.1080/00498250500136692. Xenobiotica. 2005. PMID: 16012081

5

In vitro metabolism of nefiracetam by liver microsomes from rats, dogs and monkeys.

Fujimaki Y, Sudo K, Hakusui H. Fujimaki Y, et al. Arzneimittelforschung. 1995 Jul;45(7):748-52. Arzneimittelforschung. 1995. PMID: 8573215

6

In vitro metabolism of the calmodulin antagonist DY-9760e (3-[2-[4-(3-chloro-2-methylphenyl)-1-piperazinyl]ethyl]-5,6-dimethoxy-1-(4-imidazolylmethyl)-1H-indazole dihydrochloride 3.5 hydrate) by human liver microsomes: involvement of cytochromes p450 in atypical kinetics and potential drug interactions.

Tachibana S, Fujimaki Y, Yokoyama H, Okazaki O, Sudo K. Tachibana S, et al. Among authors: fujimaki y. Drug Metab Dispos. 2005 Nov;33(11):1628-36. doi: 10.1124/dmd.105.004903. Epub 2005 Jul 27. Drug Metab Dispos. 2005. PMID: 16049129

7

Identification of urinary metabolites of ecabapide in rat.

Fujimaki Y, Hosokami T, Ono K. Fujimaki Y, et al. Xenobiotica. 1995 May;25(5):501-10. doi: 10.3109/00498259509061869. Xenobiotica. 1995. PMID: 7571723

8

Simultaneous determination of nefiracetam and its metabolites by high-performance liquid chromatography.

Fujimaki Y, Sudo K, Hakusui H. Fujimaki Y, et al. J Chromatogr. 1992 Mar 27;575(2):261-8. doi: 10.1016/0378-4347(92)80154-i. J Chromatogr. 1992. PMID: 1629302

9

Biotransformation of a new pyrrolidinone cognition-enhancing agent: isolation and identification of metabolites in human urine.

Fujimaki Y, Hashimoto K, Sudo K, Tachizawa H. Fujimaki Y, et al. Xenobiotica. 1990 Oct;20(10):1081-94. doi: 10.3109/00498259009046828. Xenobiotica. 1990. PMID: 2082597

10

Pharmacokinetics of nefiracetam and three metabolites in humans and stereoselective hydroxylation of its pyrrolidine ring.

Fujimaki Y, Sudo K, Hakusui H. Fujimaki Y, et al. Xenobiotica. 1993 Jan;23(1):61-70. doi: 10.3109/00498259309059362. Xenobiotica. 1993. PMID: 8484264

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

197 results

Search Page

Filters